We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · June 02, 2021

Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
J. Clin. Oncol 2021 May 14;[EPub Ahead of Print], JE Rosenberg, KA Ballman, S Halabi, PJ Atherton, A Mortazavi, C Sweeney, WM Stadler, BA Teply, J Picus, ST Tagawa, S Katragadda, D Vaena, J Misleh, C Hoimes, ER Plimack, TW Flaig, R Dreicer, D Bajorin, O Hahn, EJ Small, MJ Morris

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading